NASDAQ · CURR
Currenc Group, Inc.
$2.24-$0.03 (-1.1%)
Currenc Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.91% below the high.
Loading market information…
NASDAQ · HAIA · USD
Stock price, earnings
Quote as of Mar 9, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Healthcare AI Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 5.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Healthcare AI Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Healthcare AI Acquisition Corp. is presently not engaged in any significant operational activities. Its primary objective is to execute a business combination, which could take the form of a merger, share or asset acquisition, reorganization, or a similar strategic transaction, with one or more established entities. The company specifically aims to partner with businesses in the broader healthcare and pharmaceutical sectors, with a particular focus on those specializing in e-clinical solutions, healthcare information technology, or outsourced pharmaceutical services. Founded in 2021, this firm maintains its headquarters in George Town, Cayman Islands.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$2.24-$0.03 (-1.1%)
Currenc Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.91% below the high.
$9.00-$2.60 (-22.41%)
Golden Arrow Merger Corp.’s quoted price sits in the lower half of its reported 52-week range, 47.12% below the high.
$13.09$0.00 (0.0%)
Cactus Acquisition Corp. 1 Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$8.88-$1.04 (-10.48%)
Focus Impact Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 40.8% below the high.
$11.51+$0.37 (+3.32%)
Coliseum Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 15.99% below the high.
$11.99$0.00 (0.0%)
A SPAC II Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 8.72% below the high.
$5.50-$0.08 (-1.44%)
Chenghe Acquisition Co.’s quoted price sits in the lower half of its reported 52-week range, 54.73% below the high.
$10.95+$0.03 (+0.27%)
Industrial Tech Acquisitions II, Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.37% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
